PE20080552A1 - Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa - Google Patents
Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasaInfo
- Publication number
- PE20080552A1 PE20080552A1 PE2007000895A PE2007000895A PE20080552A1 PE 20080552 A1 PE20080552 A1 PE 20080552A1 PE 2007000895 A PE2007000895 A PE 2007000895A PE 2007000895 A PE2007000895 A PE 2007000895A PE 20080552 A1 PE20080552 A1 PE 20080552A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- alkyl
- pyridin
- dichloro
- ester
- Prior art date
Links
- -1 1-PHENYL-2-PYRIDINYL Chemical class 0.000 title 1
- 150000001298 alcohols Chemical class 0.000 title 1
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 title 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 3
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 2
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000002757 inflammatory effect Effects 0.000 abstract 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- MSYGAHOHLUJIKV-UHFFFAOYSA-N 3,5-dimethyl-1-(3-nitrophenyl)-1h-pyrazole-4-carboxylic acid ethyl ester Chemical compound CC1=C(C(=O)OCC)C(C)=NN1C1=CC=CC([N+]([O-])=O)=C1 MSYGAHOHLUJIKV-UHFFFAOYSA-N 0.000 abstract 1
- 239000005711 Benzoic acid Substances 0.000 abstract 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 235000010233 benzoic acid Nutrition 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
- ORGHESHFQPYLAO-UHFFFAOYSA-N vinyl radical Chemical class C=[CH] ORGHESHFQPYLAO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
REFERIDA A UN DERIVADO DE FEIL-PIRIMIDINA DE FORMULA (I), DONDE Z ES -(CH2)n, -O(CH2)m, (CH2)p, ENTRE OTROS; R4 ES H O ALQUILO C1-C6; R5 ES ALQUILO C1-C4, FENILO, BENCILO, NH2, ENTRE OTROS; n ES 0, 1 O 2; m ES 1, 2 O 3; p ES 1, 2 O 3; R1 Y R2 SON H, ALQUILO C1-C6, ALQUENILO C2-C6, ENTRE OTROS; R3 ES H, CIANO, NITRO, CF3 O HALOGENO; A ES UN SISTEMA DE ANILLOS TAL COMO FENILO, PIRAZOL, FURANO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDO CON ALQUILO C1-C6, ALQUENILO C2-C6, CICLOALQUILO C3-C7, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: ESTER (Z)-2-(3,5-DICLORO-PIRIDIN-4-IL)-1-(3,4-DIMETOXI-FENIL)-VINILICO DE ACIDO 3,4-BIMETOXI-BENZOICO, ESTER (Z)-1-(3-CICLOPENTILOXI-4-METOXI-FENIL)-2-(3,5-DICLORO-PIRIDIN-4-IL)VINILICO DE ACIDO 3-CICLOPENTILOXI-4-METOXI-BENZOICO, ESTER (Z)-2-(3,5-DICLORO-PIRIDIN-4-IL)-1-(3,4-DIMETOXI-FENIL)VINILICO DEL ACIDO BENZOICO, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA ENZIMA FOSFODIESTERASA 4 (PDE4) Y SON UTILES EN EL TRATAMIENTO DE AFECCIONES ALERGICAS E INFLAMATORIAS TALES COMO RINITIS ALERGICA, ARTRITIS INFLAMATORIA, ENFERMEDAD DE CROHN, ENTRE OTRAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06014672 | 2006-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080552A1 true PE20080552A1 (es) | 2008-06-24 |
Family
ID=38691860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000895A PE20080552A1 (es) | 2006-07-14 | 2007-07-12 | Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7671066B2 (es) |
| EP (1) | EP2044023B1 (es) |
| CN (1) | CN101490004B (es) |
| AR (1) | AR062074A1 (es) |
| AT (1) | ATE496029T1 (es) |
| DE (1) | DE602007012105D1 (es) |
| PE (1) | PE20080552A1 (es) |
| TW (1) | TW200813010A (es) |
| WO (1) | WO2008006509A1 (es) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2022783A1 (en) | 2007-08-08 | 2009-02-11 | CHIESI FARMACEUTICI S.p.A. | "Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors" |
| EP2070913A1 (en) * | 2007-12-14 | 2009-06-17 | CHIESI FARMACEUTICI S.p.A. | Ester derivatives as phosphodiesterase inhibitors |
| EP2110375A1 (en) * | 2008-04-14 | 2009-10-21 | CHIESI FARMACEUTICI S.p.A. | Phosphodiesterase-4 inhibitors belonging to the tertiary amine class |
| EP2216327A1 (en) * | 2009-02-06 | 2010-08-11 | CHIESI FARMACEUTICI S.p.A. | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors |
| EP2516423A1 (en) | 2009-12-21 | 2012-10-31 | Bayer CropScience AG | Thienylpyri (mi) dinylazole and their use for controlling phytopathogenic fungi |
| AU2011244384B2 (en) | 2010-04-21 | 2016-06-23 | Chiesi Farmaceutici S.P.A. | "Process for providing particles with reduced electrostatic charges" |
| ES2628891T3 (es) | 2010-08-03 | 2017-08-04 | Chiesi Farmaceutici S.P.A. | Formulación farmacéutica que comprende un inhibidor de fosfodiesterasa |
| CN102617457A (zh) * | 2011-01-28 | 2012-08-01 | 天津药物研究院 | 一种制备罗氟司特的新方法 |
| CN102060762B (zh) * | 2011-01-28 | 2013-05-29 | 海南美大制药有限公司 | 孟鲁司特化合物及其新制法 |
| BR112013028959A2 (pt) * | 2011-06-06 | 2016-08-30 | Chiesi Farma Spa | composto, processo para o preparo de um composto, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit |
| JP5759305B2 (ja) * | 2011-08-19 | 2015-08-05 | キヤノン株式会社 | アクセス管理システム、アクセス管理方法、アクセス管理サーバ、連携サーバ、およびプログラム |
| EP2760838B1 (en) | 2011-09-26 | 2017-05-10 | Chiesi Farmaceutici S.p.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| EP2768822B1 (en) * | 2011-10-21 | 2017-12-06 | Chiesi Farmaceutici S.p.A. | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| CN102603623A (zh) * | 2011-12-26 | 2012-07-25 | 北京赛林泰医药技术有限公司 | 制备高纯度罗氟司特的方法 |
| CN102417449A (zh) * | 2012-01-09 | 2012-04-18 | 四川蜀中制药有限公司 | 一种3-环丙基甲氧基-4-二氟甲氧基苯甲酸的制备方法 |
| WO2013131255A1 (en) | 2012-03-07 | 2013-09-12 | Scinopharm (Changshu) Pharmaceutical, Ltd. | Preparation method of roflumilast |
| KR20150022789A (ko) * | 2012-06-04 | 2015-03-04 | 키에시 파르마슈티시 엣스. 피. 에이. | 포스포디에스테라제 억제제로서 1-페닐-2-피리디닐 알킬 알코올의 유도체 |
| HK1213551A1 (zh) * | 2012-12-05 | 2016-07-08 | 奇斯药制品公司 | 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烷基醇衍生物 |
| CA2893622A1 (en) * | 2012-12-05 | 2014-06-12 | Chiesi Farmaceutici S.P.A. | Novel compounds |
| US10366264B2 (en) * | 2013-08-09 | 2019-07-30 | Korea Advanced Institute Of Science And Technology | System and method for transferring content among devices |
| US9427376B2 (en) | 2013-10-10 | 2016-08-30 | Chiesi Farmaceutici S.P.A. | Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient |
| CN114621139B (zh) * | 2013-10-22 | 2025-06-20 | 奇斯药制品公司 | 用于制备pde4抑制剂的方法 |
| CN103992220B (zh) * | 2014-06-05 | 2015-11-18 | 山东省医学科学院药物研究所 | 一种罗氟司特中间体的制备方法 |
| AU2015279428B2 (en) * | 2014-06-23 | 2018-02-15 | Leo Pharma A/S | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
| CN104447245B (zh) * | 2014-10-29 | 2017-06-06 | 成都森科制药有限公司 | 罗氟司特中间体、中间体制备方法及罗氟司特的制备方法 |
| CN104447244B (zh) * | 2014-10-29 | 2017-06-06 | 成都森科制药有限公司 | 罗氟司特中间体及罗氟司特的制备方法 |
| CN105254559B (zh) * | 2015-11-30 | 2017-07-11 | 山东罗欣药业集团股份有限公司 | 一种高纯度罗氟司特的制备方法 |
| EP3390407B1 (en) | 2015-12-18 | 2023-10-11 | UNION therapeutics A/S | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
| AU2018286964B2 (en) | 2017-06-20 | 2022-04-14 | UNION therapeutics A/S | Methods for the preparation of 1,3-benzodioxole heterocyclic compounds |
| EP3732164A1 (en) | 2017-12-28 | 2020-11-04 | Chiesi Farmaceutici S.p.A. | Use of 1-phenyl-2-pyridinyl alkyl alcohol derivatives for treating cystic fibrosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT652868E (pt) * | 1992-07-28 | 2005-01-31 | Aventis Pharma Ltd | Inibidores da fosfodiesterase do amp ciclico |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
-
2007
- 2007-07-06 WO PCT/EP2007/005982 patent/WO2008006509A1/en not_active Ceased
- 2007-07-06 CN CN2007800262568A patent/CN101490004B/zh active Active
- 2007-07-06 EP EP07785908A patent/EP2044023B1/en active Active
- 2007-07-06 AT AT07785908T patent/ATE496029T1/de not_active IP Right Cessation
- 2007-07-06 DE DE602007012105T patent/DE602007012105D1/de active Active
- 2007-07-12 PE PE2007000895A patent/PE20080552A1/es not_active Application Discontinuation
- 2007-07-12 TW TW096125354A patent/TW200813010A/zh unknown
- 2007-07-12 US US11/827,673 patent/US7671066B2/en active Active
- 2007-07-13 AR ARP070103145A patent/AR062074A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1135383A1 (en) | 2010-06-04 |
| ATE496029T1 (de) | 2011-02-15 |
| EP2044023A1 (en) | 2009-04-08 |
| DE602007012105D1 (de) | 2011-03-03 |
| US20080015226A1 (en) | 2008-01-17 |
| US7671066B2 (en) | 2010-03-02 |
| CN101490004A (zh) | 2009-07-22 |
| TW200813010A (en) | 2008-03-16 |
| WO2008006509A1 (en) | 2008-01-17 |
| AR062074A1 (es) | 2008-10-15 |
| EP2044023B1 (en) | 2011-01-19 |
| CN101490004B (zh) | 2012-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080552A1 (es) | Derivados de alcoholes 1-fenil-2-piridinil alquilenicos como inhibidores de fosfodiesterasa | |
| PE20130602A1 (es) | Derivados de 6-cicloalquil-1,5-dihidro-pirazolo(3,4-d)pirimidin-4-onas y su uso como inhibidores de pde9a | |
| PE20120355A1 (es) | DERIVADOS DE PIRAZOL COMO INHIBIDORES DE LA ENZIMA 11ßHSD1 | |
| AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
| PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
| PE20081341A1 (es) | Inhibidores de la actividad de la akt | |
| PE20071061A1 (es) | Derivados de carbonilo como inhibidores de peptidil-deformilasa (pdf) | |
| AR059957A1 (es) | DERIVADOS DE ESPIROINDOLINONA, MÉTODOS PARA SU PREPARACIoN, UNA COMPOSICIoN FARMACÉUTICA QUE LOS CONTIENE Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DEL CÁNCER. | |
| PE20141700A1 (es) | Compuestos de 2-(2,4,5-anilino sustituido) pirimidina | |
| PE20090772A1 (es) | Derivados de bencimidazol | |
| PE20140192A1 (es) | Derivados de bencimidazol como inhibidores de cinasa pi3 | |
| AR072490A1 (es) | 1,2,5- oxadiazoles como inhibidores de indolamina 2,3 dioxigenasa | |
| PE20151249A1 (es) | Derivados de pirazolopirimidina como inhibidores de jak quinasas | |
| PE20100138A1 (es) | Derivados de morfolino pirimidina usados en enfermedades relacionadas en mtor quinasa y/o pi3k | |
| PE20141582A1 (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
| PE20090698A1 (es) | Derivados de alcoholes de 1-fenil-2-piridinilalquilo como inhibidores de la fosfodiesterasa | |
| PE20110150A1 (es) | Amidofenoxiindazoles como inhibidores de c-met | |
| PE20090904A1 (es) | ARILOXAZOLES SUSTITUIDOS COMO LIGANDOS DE LOS RECEPTORES DE ADENOSINA A1 Y/O A2b | |
| ECSP088179A (es) | Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos | |
| PE20091066A1 (es) | 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-onas, un proceso para su produccion y su uso como agentes antiinflamatorios | |
| PE20191528A1 (es) | Nuevos derivados de triazolo[4,5-d]pirimidina | |
| PE20081753A1 (es) | Compuestos y composiciones como inhibidores de la proteasa activadora de canal | |
| PE20110384A1 (es) | Derivados de carbamatos de alquiltiazoles y su preparacion | |
| AR056103A1 (es) | Compuestos de(piran-piperidinil)benzimidazol, composiciones farmaceuticas que los comprenden, proceso de preparacion y usos en el tratamiento de afecciones mediadas por agonistas del receptor muscarinico m1 | |
| PE20091182A1 (es) | DERIVADOS DE IMIDAZO[1,2-a]PIRIDIN-2-CARBOXAMIDAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |